Target intelligence / Profile preview

Mycobacterium leprae antigen

Molecular classification
Other
01

Overview

Mycobacterium leprae antigens are a diverse set of molecular structures, primarily proteins and glycolipids, derived from the bacterium Mycobacterium leprae, which causes leprosy. These antigens elicit immune responses in infected individuals and serve as the basis for several diagnostic tools. The most notable antigens include cell wall proteins, membrane proteins, cytosolic antigens, and the phenolic glycolipid-1 (PGL-I). Some antigens such as ML0405, ML2331, and MAL5/MMP-I show high specificity and sensitivity as biomarkers for serological diagnosis. While not in themselves therapeutic targets (in contrast to essential enzymes like dihydropteroate synthase or RNA polymerase), they play key roles in infection, immune recognition, and pathology, and are actively used in immunodiagnostics for leprosy. Because “M. leprae antigens” is a non-specific, catch-all term, it is not strictly correct as a molecular target; appropriate specificity would name the individual antigen of interest (e.g., ML0405, PGL-I).

Other names
M. leprae antigenLeprae antigensM. leprae proteinsM. leprae cell wall antigensM. leprae membrane antigens
02

Biological functions

Immune responseImmune evasionPathogenesisAntigen presentation
03

Disease associations

Infection
04

Safety considerations

Antigen cross-reactivity may limit specificity for diagnosticsnot used as drug targets
05

Biomarkers

ML0405ML2331natural disaccharide O-linked human serum albumin (synthetic PGL-I)MAL5 (MMP-I)M. leprae-specific cell wall/membrane/cytosolic protein markers

Beyond the preview

Go deeper on Mycobacterium leprae antigen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterium leprae antigen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call